nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antileukemia activity of the combination of 5-aza-2′-deoxycytidine with valproic acid
|
Yang, Hui |
|
2005 |
29 |
7 |
p. 739-748 10 p. |
artikel |
2 |
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α
|
Rosati, Emanuela |
|
2005 |
29 |
7 |
p. 829-839 11 p. |
artikel |
3 |
Combined targeting of the epigenetic silence in leukemia: Cooperating activities of DNA methylation and histone deacetylation inhibitors
|
Lübbert, Michael |
|
2005 |
29 |
7 |
p. 727-728 2 p. |
artikel |
4 |
Cytotoxic effects of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine in cross-resistant H9 human lymphoma cells
|
Saiko, Philipp |
|
2005 |
29 |
7 |
p. 785-791 7 p. |
artikel |
5 |
Establishment and characterization of SRIK-NKL: a novel CD8+ natural killer/T cell line derived from a patient with leukemic phase of acute lymphoblastic lymphoma
|
Srivastava, Bejai I.S. |
|
2005 |
29 |
7 |
p. 771-783 13 p. |
artikel |
6 |
Experimental myelofibrosis in mice and the implications to human disease
|
Tefferi, Ayalew |
|
2005 |
29 |
7 |
p. 723-726 4 p. |
artikel |
7 |
Expression of mRNA and proteins for toll-like receptors, associated molecules, defensins and LL-37 by SRIK-NKL, a CD8+ NK/T cell line
|
Srivastava, Maya D. |
|
2005 |
29 |
7 |
p. 813-820 8 p. |
artikel |
8 |
GM-CSF does not increase CD20 antigen expression on chronic lymphocytic leukemia lymphocytes
|
Yağcı, Münci |
|
2005 |
29 |
7 |
p. 735-738 4 p. |
artikel |
9 |
Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells
|
Shibakura, Misako |
|
2005 |
29 |
7 |
p. 755-759 5 p. |
artikel |
10 |
Leukemic cell death induced by antithymocyte globulin
|
Yoshimi, Ayami |
|
2005 |
29 |
7 |
p. 821-827 7 p. |
artikel |
11 |
Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation
|
Walsh, Sarah H. |
|
2005 |
29 |
7 |
p. 729-734 6 p. |
artikel |
12 |
Minimal residual disease based on patient specific Flt3-ITD and -ITT mutations in acute myeloid leukemia
|
Scholl, Sebastian |
|
2005 |
29 |
7 |
p. 849-853 5 p. |
artikel |
13 |
Myelodysplastic syndromes in patients under 50 years old: a single institution experience
|
Breccia, Massimo |
|
2005 |
29 |
7 |
p. 749-754 6 p. |
artikel |
14 |
Submicroscopic deletions in an acute myeloid leukemia case with a four-way t(8;11;16;21)
|
Albano, Francesco |
|
2005 |
29 |
7 |
p. 855-858 4 p. |
artikel |
15 |
The tyrosine kinase inhibitors imatinib and AG957 reverse multidrug resistance in a chronic myelogenous leukemia cell line
|
Yeheskely-Hayon, Daniella |
|
2005 |
29 |
7 |
p. 793-802 10 p. |
artikel |
16 |
Transcription factor expression in B-cell precursor-leukemia cell lines: preferential expression of T-bet
|
Harashima, Akira |
|
2005 |
29 |
7 |
p. 841-848 8 p. |
artikel |
17 |
Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis
|
Kakumitsu, Haruko |
|
2005 |
29 |
7 |
p. 761-769 9 p. |
artikel |
18 |
Wt1 is not essential for hematopoiesis in the mouse
|
King-Underwood, Linda |
|
2005 |
29 |
7 |
p. 803-812 10 p. |
artikel |